Abstract:An androgen receptor (AR) is an intensively studied treatment target for castration-resistant prostate cancer that is irresponsive to conventional antiandrogen therapeutics. Binding function 3 (BF3) inhibitors with alternative modes of action have emerged as a promising approach to overcoming antiandrogen resistance. However, how these BF3 inhibitors modulate AR function remains elusive, hindering the development of BF3-targeting agents. Here, we performed an integrated computational study to interrogate the binding mechanism of several known BF3 inhibitors with ARs. Our results show that the inhibitory effect of the BF3 antagonists arises from their allosteric modulation of the activation function (AF2) site, which alters the dynamic coupling between the BF3 and AF2 sites as well as the AF2-coactivator (SRC2-3) interaction. Moreover, the per-residue binding energy analyses reveal the "anchor" role of the linker connecting the phenyl ring and benzimidazole/indole in these BF3 inhibitors. Furthermore, the allosteric driver-interacting residues are found to include both "positive", e.g., Phe673 and Asn833, and "negative" ones, e.g., Phe826, and the differential interactions with these residues provide an explanation why stronger binding does not necessarily result in higher inhibitory activities. Finally, our allosteric communication pathway analyses delineate how the allosteric signals triggered by BF3 binding are propagated to the AF2 pocket through multiple short- and/or long-ranged transmission pathways. Collectively, our combined computational study provides a comprehensive structural mechanism underlying how the selected set of BF3 inhibitors modulate AR function, which will help guide future development of BF3 antagonists.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.1c00124?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.1c00124</a>.Structure and biological activity of BF3 antagonists with the benzimidazole scaffold; binding energies including contributions from enthalpy (ΔEele + ΔEvdW + ΔGGB + ΔGSA) and entropy (−TΔS) changes; per-residue binding energies and corresponding components of key residues; binding free energies and the corresponding energy terms of SRC23 peptide with AF2 in BF3 bound and unbound ARs; key residues involved in the interaction between ARs and SRC23; predicted allosteric BF3 → AF2 pathways in androgen-bound ARs by the Monte Carlo (MC) path generation approach; RMSDs of backbone atoms as a function of simulation time for AR/TES/SRC23; structural comparison of the AF2 surfaces; differences in the SRC binding interaction energy contributions of individual AR residues; community structures of residue contact networks; and propensities of residues being sensors/effectors mapped onto ribbon diagrams of AR and the corresponding PRS maps of the BF3 antagonistic AR/TES in complex with BF3 antagonists (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.1c00124/suppl_file/ci1c00124_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Structural Diversity of Ligand-Binding Androgen Receptors Revealed by Microsecond Long Molecular Dynamics Simulations and Enhanced Sampling

Molecular Dynamics Simulations Revealed the Regulation of Ligands to the Interactions between Androgen Receptor and Its Coactivator

Conformational dynamics of androgen receptors bound to agonists and antagonists

Communication between the Ligand-Binding Pocket and the Activation Function-2 Domain of Androgen Receptor Revealed by Molecular Dynamics Simulations

Communication between the ligand-binding pocket (LBP) and the activation function-2 (AF2) domain of androgen receptor revealed by molecular dynamics simulations.

Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays

Computational Analysis of Residue-Specific Binding Free Energies of Androgen Receptor to Ligands

In silico study on hydroxylated polychlorinated biphenyls as androgen receptor antagonists.

Synthesis and Modeling of Novel Α-Aminoalkylphosphonate Ester Derivatives As Potent Inhibitors of Prostate-Specific Antigen; A Comparison Study

Discovery of Novel Anti‐Resistance AR Antagonists Guided by Funnel Metadynamics Simulation

Discovery of a Novel Androgen Receptor Antagonist Manifesting Evidence to Disrupt the Dimerization of the Ligand-Binding Domain via Attenuating the Hydrogen-Bonding Network Between the Two Monomers

Small-Molecule Inhibition of Androgen Receptor Dimerization As a Strategy Against Prostate Cancer

Detection of ligand-selective interactions of the human androgen receptor by SELDI-MS-TOF

Exploring inhibitory components of Hedyotis diffusa on androgen receptor through molecular docking and molecular dynamics simulations

Understanding Aldose Reductase-Inhibitors interactions with free energy simulation

Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays

Docking and CoMSIA Studies on Steroids and Non-Steroidal Chemicals As Androgen Receptor Ligands.

Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors

Novel Androgen Receptor Antagonist Identified by Structure-Based Virtual Screening, Structural Optimization, and Biological Evaluation.

Advances in the computational development of androgen receptor antagonists

Mechanistic Insights into the Allosteric Inhibition of Androgen Receptors by Binding Function 3 Antagonists from an Integrated Molecular Modeling Study